FDA Analysis of Atorvastatin Products Refutes Report of Methyl Ester Impurities

Abstract

Get full access to this article

View all access options for this article.

References

Mason

Jacob

Gerard

. Atorvastatin generics obtained from multiple sources worldwide contain a methylated impurity that reduces their HMG-CoA reductase inhibitory effects. J Clin Lipidol. 2013; 7: 287.

Businessweek. Substandard generic drugs slip past US FDA effort, doctors say. http://www.businessweek.com/news/2014-02-26/fda-failed-to-track-substandard-generic-medicines-congress-told.

Mason

Gerard

Jacob

. Atorvastatin generics obtained from multiple sources worldwide contain a methylated impurity that reduces their HMG-CoA reductase inhibitory effects. http://www.lipid.org/util/eposters/PDFs/183%20-%20Maso.pdf. Accessed March 1, 2014.

Woodcock

Khan

. Withdrawal of generic Budeprion for nonbioequivalence. N Engl J Med. 2012;367:2463–2465.